MedPath

OTICARA AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Phase 2
Recruiting
Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
Device: Pre-filled syringe and applicator device
First Posted Date
2023-05-31
Last Posted Date
2024-11-12
Lead Sponsor
Oticara Australia PTY LTD
Target Recruit Count
24
Registration Number
NCT05882903
Locations
🇦🇺

Oticara Investigational Site, Perth, Western Australia, Australia

Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

Phase 1
Terminated
Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
Device: Pre-filled syringe and applicator device
First Posted Date
2022-02-02
Last Posted Date
2024-05-02
Lead Sponsor
Oticara Australia PTY LTD
Target Recruit Count
2
Registration Number
NCT05220293
Locations
🇦🇺

Oticara Clinical Trial Site, Sydney, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath